1. Bufalin Induces Apoptotic Cell Death in Human Nasopharyngeal Carcinoma Cells through Mitochondrial ROS and TRAIL Pathways
   En-Yun Su et al, 2019, Am. J. Chin. Med. CrossRef
2. null
   Geeta Rai, 2019 CrossRef
3. Long noncoding RNA ADAMTS9‐AS2 suppresses the progression of esophageal cancer by mediating CDH3 promoter methylation
   Donglei Liu et al, 2019, Mol Carcinog CrossRef
4. ZnO Nanoparticles Induced Caspase-Dependent Apoptosis in Gingival Squamous Cell Carcinoma through Mitochondrial Dysfunction and p70S6K Signaling Pathway
   Shih-Wei Wang et al, 2020, IJMS CrossRef
5. Bufalin down-regulates Axl expression to inhibit cell proliferation and induce apoptosis in non-small-cell lung cancer cells
   Nam-Yi Kim et al, 2020 CrossRef
6. Bufalin inhibits ovarian carcinoma via targeting mTOR/HIF‐α pathway
   Shan Su et al, 2020, Basic Clin. Pharmacol. Toxicol. CrossRef
7. Effects of low‑dose bufalin combined with hydroxycamptothecin on human castration‑resistant prostate cancer xenografts in nude mice
   Renze Gu et al, 2021, Exp Ther Med CrossRef
8. miR-301-3p directly regulates Cx43 to mediate the development of gastric cancer
   Shasha Liu et al, 2021, J Int Med Res CrossRef
9. Bufalin for an innovative therapeutic approach against cancer
   Laura Soumoy et al, 2022, Pharmacological Research CrossRef
10. Bufalin-Mediated Regulation of Cell Signaling Pathways in Different Cancers: Spotlight on JAK/STAT, Wnt/β-Catenin, mTOR, TRAIL/TRAIL-R, and Non-Coding RNAs
    Ammad Ahmad Farooqi et al, 2023, Molecules CrossRef